# MEMANTINE HYDROCHLORIDE
> **ANDA210319** · Abbreviated New Drug Application (Generic) · Sponsor: MEDLEY PHARMS · Approved 2020-08-31
## Drug
- **FDA Application Number:** ANDA210319
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MEMANTINE HYDROCHLORIDE
- **Generic name:** MEMANTINE HYDROCHLORIDE ORAL
- **Active ingredients:** MEMANTINE HYDROCHLORIDE
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MEDLEY PHARMS
- **Manufacturer:** Seton Pharmaceuticals
- **First approval:** 2020-08-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210319)
---
*AI Analytics · CC0 1.0*